Results 131 to 140 of about 27,553,759 (265)

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Excerpt, Oral History Interview, Sadami Yada Hamamoto

, 1982
Excerpt, summary, and index of an oral history interview of Sadami Yada Hamamoto. Conducted by Eric Saul on May 31, 1982, in Little Rock, AR. Transcriber unknown. Edited by Megan Udell and Yi-Shen Loo.This oral history interview was conducted for the MIS
Sadami Yada Hamamoto, Eric Saul
core  

Cancer‐associated mutations in endometriosis reframe a benign disease through molecular oncology

Molecular Oncology, EarlyView.
This review aims to comprehensively analyse cancer‐associated somatic mutations (CAMs) present in endometriotic lesions, emphasizing their biological roles, spatial distribution and implications for translational applications in medicine. By contextualizing a benign state within a genomic framework, this analysis seeks to establish its value as a ...
Clarissa Mujacic, Maria Concetta Vitale, Rita Siino, Emilia Di Giovanni, Carla Ferrante Bannera, Enrico Di Marco, Andrea Gottardo, Tancredi Didier Bazan Russo, Nadia Barraco, Alessandro Perez, Valerio Gristina, Antonio Galvano, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan, Lorena Incorvaia   +15 more
wiley   +1 more source

Chronic Pain and Newly Reported Frequent Feelings of Depression: A Nationally Representative Longitudinal Study in 2019-2020. [PDF]

J Pain Res
Zang H, Li T, Zhang Y, Che L, Cui Q, Xiao C, Wen B, Xu L.   +7 more
europepmc   +1 more source

Excerpt, Oral History Interview, Jim Yamaguchi

Excerpt, summary, and index of an oral history interview of Jim Yamaguchi. Interviewer unknown. Transcribed by Yi-Shen Loo.This oral history interview was conducted for the MIS Oral History Project by the Military Intelligence Service Association of ...
Jim Yamaguchi
core  

National Woman's Party State Delegators

, 1910
This is a document published by the National Woman's Party that lists the delegates of states within the party. The National Woman's Party originated in 1913 when the Congressional Union for Woman Suffrage began its work to secure the enfranchisement ...
National Woman's Party
core  

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Local endothelin-1 receptor type A antagonism improves cutaneous microvascular function in women with a history of gestational diabetes mellitus. [PDF]

Am J Physiol Heart Circ Physiol
Maurer GS, Whitaker KM, Jalal DI, Stanhewicz AE.   +3 more
europepmc   +1 more source

Excerpt, Oral History Interview, Yukio Wada

, 1994
Excerpt, summary, and index of an oral history interview of Yukio Wada. Conducted by Marcy Mamiya, Mike Honda, Lisa Hirai, and Chizu Iiyama in 1994 in Walnut Creek, CA.
Yukio Wada, Marcy Mamiya, Mike Honda, Lisa Hirai, Chizu Iiyama   +1 more
core  

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source